DK1379671T3 - Fremgangsmåder til dyrkning af circovirus - Google Patents
Fremgangsmåder til dyrkning af circovirusInfo
- Publication number
- DK1379671T3 DK1379671T3 DK02712700T DK02712700T DK1379671T3 DK 1379671 T3 DK1379671 T3 DK 1379671T3 DK 02712700 T DK02712700 T DK 02712700T DK 02712700 T DK02712700 T DK 02712700T DK 1379671 T3 DK1379671 T3 DK 1379671T3
- Authority
- DK
- Denmark
- Prior art keywords
- methods
- culturing
- circovirus
- present
- culturing circovirus
- Prior art date
Links
- 238000012258 culturing Methods 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 241001533384 Circovirus Species 0.000 title abstract 2
- 241000202347 Porcine circovirus Species 0.000 abstract 2
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 241000701161 unidentified adenovirus Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10041—Use of virus, viral particle or viral elements as a vector
- C12N2750/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10051—Methods of production or purification of viral material
- C12N2750/10052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27917301P | 2001-03-27 | 2001-03-27 | |
| PCT/CA2002/000413 WO2002077210A2 (en) | 2001-03-27 | 2002-03-27 | Methods to culture circovirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1379671T3 true DK1379671T3 (da) | 2009-06-29 |
Family
ID=23067939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK02712700T DK1379671T3 (da) | 2001-03-27 | 2002-03-27 | Fremgangsmåder til dyrkning af circovirus |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US6794163B2 (de) |
| EP (1) | EP1379671B1 (de) |
| JP (1) | JP4038127B2 (de) |
| KR (1) | KR100876629B1 (de) |
| CN (2) | CN1840656B (de) |
| AT (1) | ATE430807T1 (de) |
| AU (1) | AU2002244584B2 (de) |
| BR (1) | BRPI0208456B8 (de) |
| CA (1) | CA2442135C (de) |
| CY (1) | CY1109267T1 (de) |
| CZ (1) | CZ304525B6 (de) |
| DE (1) | DE60232234D1 (de) |
| DK (1) | DK1379671T3 (de) |
| ES (1) | ES2324466T3 (de) |
| HU (1) | HU228065B1 (de) |
| MX (1) | MXPA03008810A (de) |
| MY (2) | MY146518A (de) |
| PL (1) | PL202951B1 (de) |
| PT (1) | PT1379671E (de) |
| RU (2) | RU2312142C2 (de) |
| SK (1) | SK287969B6 (de) |
| UA (1) | UA82647C2 (de) |
| WO (1) | WO2002077210A2 (de) |
| ZA (1) | ZA200307517B (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2772047B1 (fr) * | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
| US20040062775A1 (en) * | 1997-12-05 | 2004-04-01 | Agence Francaise De Securite Sanitaire Des Aliments | Circovirus sequences associated with piglet weight loss disease (PWD) |
| ES2170622B1 (es) * | 1999-12-03 | 2004-05-16 | Consejo Superior De Investigaciones Cientificas | Clones y vectores infectivos derivados de coronavirus y sus aplicaciones. |
| KR100876629B1 (ko) * | 2001-03-27 | 2009-01-07 | 유니버시티 오브 사스카췌완 | 써코바이러스의 배양 방법 |
| US20030096377A1 (en) * | 2001-06-28 | 2003-05-22 | Virginia Tech Intellectual Properties, Inc. | Differential PCR-RFLP assay for detecting and distinguishing between nonpathogenic PCV-1 and pathogenic PCV-2 |
| US7276353B2 (en) | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| US7279166B2 (en) | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
| US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
| US7833707B2 (en) * | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
| UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| PL2275132T3 (pl) | 2005-12-29 | 2021-09-13 | Boehringer Ingelheim Animal Health USA Inc. | Multiwalentne immunogenne kompozycje PCV2 i sposoby ich wytwarzania |
| CN109125721A (zh) * | 2005-12-29 | 2019-01-04 | 贝林格尔.英格海姆维特梅迪卡有限公司 | Pcv2免疫原性组合物用于减轻猪临床症状的用途 |
| EP2859900A1 (de) * | 2006-12-11 | 2015-04-15 | Boehringer Ingelheim Vetmedica, Inc. | Wirksames Verfahren zur Behandlung von Infektionen mit dem porcinen Circovirus und Lawsonia intracellularis |
| CN107412761A (zh) * | 2006-12-15 | 2017-12-01 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 以pcv2抗原治疗猪 |
| EP1941903A1 (de) * | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxe und Behandlung von PRDC |
| EP1958644A1 (de) * | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Vorbeugung und Behandlung von subklinischer PCVD |
| US8518696B2 (en) * | 2007-05-11 | 2013-08-27 | Temasek Life Sciences Laboratory Limited | Production of homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection |
| WO2008151215A1 (en) * | 2007-06-04 | 2008-12-11 | Merial Limited | Production of porcine circovirus proteins in plants |
| US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
| ME01156B (me) * | 2007-12-21 | 2013-03-20 | Zoetis Services Llc | Postupci i kompozicije za imunizaciju svinja protiv svinjskog cirkovirusa |
| AU2008347235A1 (en) * | 2007-12-31 | 2009-07-16 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 ORF2 virus like particle with foreign amino acid insertion |
| EP2242511A4 (de) * | 2008-01-23 | 2012-10-24 | Boehringer Ingelheim Vetmed | Immunogene pcv2-zusammensetzungen gegen mycoplasma hyopneumoniae und verfahren zur herstellung solcher zusammensetzungen |
| EP2276507A4 (de) * | 2008-04-16 | 2011-11-16 | Virginia Tech Intell Prop | Chimäres circovirus pcv2gen-1rep vom schwein und verwendungen dafür |
| TWI627281B (zh) * | 2009-09-02 | 2018-06-21 | 百靈佳殷格翰家畜藥品公司 | 降低ｐｃｖ－２組合物殺病毒活性之方法及具有改良免疫原性之ｐｃｖ－２組合物 |
| US20120100168A1 (en) * | 2010-01-25 | 2012-04-26 | Blood Systems, Inc. | Cyclovirus and methods of use |
| JP6821429B2 (ja) | 2013-09-25 | 2021-01-27 | ゾエティス・サービシーズ・エルエルシー | Ｐｃｖ２ｂ分岐ワクチン組成物及び使用方法 |
| WO2015051099A1 (en) | 2013-10-02 | 2015-04-09 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 orf2 protein variant and virus like particles composed thereof |
| MX2017014414A (es) | 2015-05-14 | 2018-03-16 | Merial Inc | Metodo para la produccion de circovirus porcino y vacunas pcv2. |
| WO2018071511A1 (en) * | 2016-10-11 | 2018-04-19 | Orion Labs | Group communication forwarding to a secondary service |
| CN114934020B (zh) * | 2022-01-30 | 2024-02-13 | 山东省滨州畜牧兽医研究院 | 猪视网膜上皮细胞系及其建立方法和应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2751712C (en) * | 1996-10-23 | 2016-11-22 | The Trustees Of The University Of Pennsylvania | Immunotherapy and improved vaccines |
| AUPO856097A0 (en) | 1997-08-14 | 1997-09-04 | Commonwealth Scientific And Industrial Research Organisation | Vector |
| US6391314B1 (en) | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
| US7192594B2 (en) * | 1997-10-03 | 2007-03-20 | Merial Limited | Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| UA78180C2 (uk) | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
| FR2781159B1 (fr) * | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
| US6517843B1 (en) * | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
| FR2772047B1 (fr) | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
| WO1999045956A1 (en) | 1998-03-13 | 1999-09-16 | University Of Georgia Research Foundation, Inc. | Vaccines against circovirus infections |
| US6492343B1 (en) | 1998-04-15 | 2002-12-10 | University Of Saskatchewan | Porcine adenovirus type 3 genome |
| EP1112274B1 (de) | 1998-09-08 | 2009-12-09 | Brij P. Giri | Chemolumineszente 1,2-dioxetane |
| US6458586B1 (en) * | 1998-11-02 | 2002-10-01 | University Of Saskatchewan | Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| FR2789695B1 (fr) | 1999-02-11 | 2003-03-07 | Merial Sas | Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs |
| US6943152B1 (en) * | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
| US6497883B1 (en) | 1999-06-10 | 2002-12-24 | Merial | Porcine circovirus recombinant poxvirus vaccine |
| EP1311698A2 (de) * | 2000-05-03 | 2003-05-21 | University Of Guelph | Schweine-adenovirus 5 vektor und impfstoff |
| KR100876629B1 (ko) * | 2001-03-27 | 2009-01-07 | 유니버시티 오브 사스카췌완 | 써코바이러스의 배양 방법 |
-
2002
- 2002-03-27 KR KR1020037012491A patent/KR100876629B1/ko active IP Right Grant
- 2002-03-27 PL PL364077A patent/PL202951B1/pl unknown
- 2002-03-27 MX MXPA03008810A patent/MXPA03008810A/es active IP Right Grant
- 2002-03-27 EP EP02712700A patent/EP1379671B1/de not_active Expired - Lifetime
- 2002-03-27 DE DE60232234T patent/DE60232234D1/de not_active Expired - Lifetime
- 2002-03-27 CN CN2006100731464A patent/CN1840656B/zh not_active Expired - Lifetime
- 2002-03-27 RU RU2003131342/13A patent/RU2312142C2/ru active
- 2002-03-27 ES ES02712700T patent/ES2324466T3/es not_active Expired - Lifetime
- 2002-03-27 MY MYPI20021106A patent/MY146518A/en unknown
- 2002-03-27 BR BRPI0208456A patent/BRPI0208456B8/pt active IP Right Grant
- 2002-03-27 US US10/112,540 patent/US6794163B2/en not_active Expired - Lifetime
- 2002-03-27 AT AT02712700T patent/ATE430807T1/de active
- 2002-03-27 UA UA2003109561A patent/UA82647C2/uk unknown
- 2002-03-27 CZ CZ2003-2584A patent/CZ304525B6/cs not_active IP Right Cessation
- 2002-03-27 AU AU2002244584A patent/AU2002244584B2/en not_active Expired
- 2002-03-27 HU HU0500161A patent/HU228065B1/hu unknown
- 2002-03-27 MY MYPI2011006359A patent/MY148759A/en unknown
- 2002-03-27 CA CA002442135A patent/CA2442135C/en not_active Expired - Lifetime
- 2002-03-27 PT PT02712700T patent/PT1379671E/pt unknown
- 2002-03-27 JP JP2002576653A patent/JP4038127B2/ja not_active Expired - Lifetime
- 2002-03-27 CN CNB02809221XA patent/CN1309836C/zh not_active Expired - Lifetime
- 2002-03-27 WO PCT/CA2002/000413 patent/WO2002077210A2/en active Application Filing
- 2002-03-27 DK DK02712700T patent/DK1379671T3/da active
- 2002-03-27 SK SK1210-2003A patent/SK287969B6/sk unknown
-
2003
- 2003-09-26 ZA ZA200307517A patent/ZA200307517B/en unknown
-
2004
- 2004-05-07 US US10/840,879 patent/US7172899B2/en not_active Expired - Lifetime
-
2007
- 2007-01-17 US US11/654,869 patent/US7560278B2/en not_active Expired - Lifetime
- 2007-03-23 RU RU2007110808/13A patent/RU2007110808A/ru not_active Application Discontinuation
-
2009
- 2009-08-04 CY CY20091100822T patent/CY1109267T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1379671T3 (da) | Fremgangsmåder til dyrkning af circovirus | |
| DK1210411T3 (da) | Sammensætninger og fremgangsmåder til forbedret celledyrkning | |
| DK1749543T3 (da) | Sammensætning til vævsregeneration | |
| TW200611910A (en) | Interferon-alpha polypeptides and conjugates | |
| EP3486314A3 (de) | Plazentastammzellenpopulationen | |
| WO2006108183A3 (en) | Label free biosensors and cells | |
| ATE500323T1 (de) | Subtilisin-variante | |
| MY163480A (en) | Sclerostin binding agents | |
| AU2019268061A1 (en) | Placental stem cell populations | |
| HK1063334A1 (en) | Compositions and methods useful for hcv infection | |
| TW200716130A (en) | Purified form of tanaproget | |
| DK1456238T3 (da) | Produktion af F(ab')2-fragmenter i pattedyrceller | |
| ATE252574T1 (de) | Benzofuran-2-ones als färbemittel für organische materialien | |
| AU2003288621A1 (en) | Rna bioassay | |
| EA200801385A1 (ru) | Способ образования дендритных клеток с применением пониженной температуры | |
| WO2002062970A8 (en) | Enteric nervous system derived stem and progenitor cells and uses thereof | |
| NO20040174L (no) | Fremgangsmate for donorspesifikk krysstilpasning | |
| ATE374243T1 (de) | Knorpelzell-kulturmedium und verwendung desselben | |
| GEP20074120B (en) | Subcutaneously-administered ganglioside-based vaccine compositions |